PE119299A1 - Composicion farmaceutica para el tratamiento de la dismenorrea y el parto prematuro - Google Patents

Composicion farmaceutica para el tratamiento de la dismenorrea y el parto prematuro

Info

Publication number
PE119299A1
PE119299A1 PE00086798A PE00086798A PE119299A1 PE 119299 A1 PE119299 A1 PE 119299A1 PE 00086798 A PE00086798 A PE 00086798A PE 00086798 A PE00086798 A PE 00086798A PE 119299 A1 PE119299 A1 PE 119299A1
Authority
PE
Peru
Prior art keywords
dysmenorrhea
treatment
composition
pharmaceutical composition
adrenoceptors
Prior art date
Application number
PE00086798A
Other languages
English (en)
Inventor
Ziegler Dominique De
William J Bologna
Howard L Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of PE119299A1 publication Critical patent/PE119299A1/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

CARACTERIZADO PORQUE COMPRENDE: a)UN AGONISTA DE RECEPTORES �-ADRENERGICO COMO TERBUTALINA UTILIZANDOSE DE 1 mg A 4 mg; b)UN PORTADOR BIOADHESIVO QUE COMPRENDE UN POLIMERO CARBOXILICO ENTRECRUZADO TAL COMO POLICARBOFILO. LA COMPOSICION FARMACEUTICA PUEDE SER DE ADMINISTRACION VAGINAL. LA TERBUTALINA PUEDE SER UTIL PARA TRATAR LA DISMENORREA, EL PARTO PREMATURO
PE00086798A 1997-09-12 1998-09-11 Composicion farmaceutica para el tratamiento de la dismenorrea y el parto prematuro PE119299A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5878997P 1997-09-12 1997-09-12

Publications (1)

Publication Number Publication Date
PE119299A1 true PE119299A1 (es) 1999-12-01

Family

ID=22018939

Family Applications (1)

Application Number Title Priority Date Filing Date
PE00086798A PE119299A1 (es) 1997-09-12 1998-09-11 Composicion farmaceutica para el tratamiento de la dismenorrea y el parto prematuro

Country Status (7)

Country Link
AR (1) AR016650A1 (es)
MA (1) MA26546A1 (es)
MY (1) MY116275A (es)
PE (1) PE119299A1 (es)
RU (1) RU2219905C2 (es)
UA (1) UA62983C2 (es)
ZA (1) ZA988328B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
RU2578476C1 (ru) * 2015-03-31 2016-03-27 государственное бюджетное образовательное учреждение высшего профессионального образования"Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации Способ лечения угрожающих преждевременных родов

Also Published As

Publication number Publication date
RU2219905C2 (ru) 2003-12-27
AR016650A1 (es) 2001-07-25
MA26546A1 (fr) 2004-12-20
UA62983C2 (en) 2004-01-15
MY116275A (en) 2003-12-31
ZA988328B (en) 1999-02-23

Similar Documents

Publication Publication Date Title
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
ATE253892T1 (de) Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
DE60117043D1 (de) Behandlung von mukositis
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
CA2359510A1 (en) .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
BR0315688A (pt) Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
GEP20043375B (en) APRIL-Receptor (BCMA) and Use Thereof
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
BG101118A (en) Therapeutical compounds
FI973419A (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
EE200000054A (et) Vitamiini D ja kaltsiumit sisaldav ravimkoostis, selle valmistamine ja terapeutiline kasutamine
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
SE9802937D0 (sv) Novel compounds
ATE198278T1 (de) Verwendung von sulodexid und von arzneimitteln, die dieses enthalten, zur behandlung der diabetischen nephropathie
BR9709316A (pt) Composição farmacêutica para administração tópica no tratamento da vaginite
FR2718020B1 (fr) Composition galénique mucoadhésive hétérofonctionnelle.
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
ATE302210T1 (de) Histogranin peptide und deren analgetische verwendung
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
MD970244A (en) Dimer lysozime new application
PE119299A1 (es) Composicion farmaceutica para el tratamiento de la dismenorrea y el parto prematuro

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed